← Search & browse all drugs
ALIMENTARY TRACT AND METABOLISM › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › Other drugs for functional gastrointestinal disorders
chlorbenzoxamine
A03AX03
Forms & Strengths
- Oral tablets: 10 mg
- Combination formulations exist with antispasmodics or sedatives depending on regional availability
Adult Dosing
- 10 to 20 mg orally three times daily before meals
- Maximum daily dose generally not to exceed 60 mg
Pediatric Dosing
- Safety and efficacy in pediatric patients not established
- Use in children is generally not recommended
Indications
- Symptomatic relief of gastrointestinal hypermotility
- Visceral spasms associated with irritable bowel syndrome and gastritis
Mechanism of Action
- Anticholinergic and antispasmodic agent
- Exerts direct relaxant effects on gastrointestinal smooth muscle
- Competitively blocks muscarinic acetylcholine receptors to reduce secretions and motility
Contraindications
- Known hypersensitivity to chlorbenzoxamine
- Angle-closure glaucoma
- Gastrointestinal tract obstruction, paralytic ileus, or toxic megacolon
- Severe obstructive uropathy or prostatic hyperplasia with urinary retention
- Myasthenia gravis
Adverse Reactions
- Dry mouth, blurred vision, and mydriasis
- Constipation and urinary retention
- Tachycardia and palpitations
- Drowsiness, dizziness, and headache
- Reduced sweating leading to potential heat intolerance
Drug Interactions
- Additive anticholinergic effects with tricyclic antidepressants, antihistamines, and antiparkinsonian drugs
- May alter gastrointestinal absorption of other oral medications due to decreased motility
- Enhances sedative effects when co-administered with central nervous system depressants or alcohol
Curated Content: Needs Vetting Before Put to Clinical Use